RadNet, Inc.

NASDAQ•RDNT

CEO: Dr. Howard G. Berger M.D.

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Listing Date: 1997-01-03

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Contact Information

1510 Cotner Avenue, Los Angeles, CA, 90025, United States

310-478-7808

www.radnet.com

Market Cap

$4.45B

P/E (TTM)

-229.2

31.7

Dividend Yield

52W High

$85.84

52W Low

$50.76

52W Range

17%

Rank58Top 85.6%

2.3

F-Score

Modified Piotroski Analysis

Based on 10-year fundamentals

Weak • 2.3 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$547.71M+0.00%

4-Quarter Trend

EPS

-$0.01+0.00%

4-Quarter Trend

FCF

-$230.86M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Total Revenue Rises 10.9% Consolidated revenue reached $2.040 B USD in 2025, marking a 10.9% increase driven by higher fees and volumes.

Imaging Center Revenue Grows Imaging Center revenue increased 10.9% to $1.988 B USD, fueled by organic growth and 20 centers acquired in 2025.

Digital Health Revenue Accelerates Digital Health segment revenue jumped 41.1% to $92.7 M USD, reflecting integration of iCAD and other AI acquisitions.

Operating Cash Flow Improves Cash provided by operating activities increased $65.8 M USD to $298.8 M USD, driven by favorable working capital changes.

Risk Factors

Net Loss Attributable Stockholders Net loss attributable to common stockholders was $(18.652) M USD in 2025, reversing prior year's net income.

Digital Health Segment Losses Widen Digital Health segment operating loss widened to $(32.297) M USD due to integration costs and ongoing investment scaling.

Fixed Costs Pressure Margins High fixed costs combined with potential reimbursement rate reductions could materially reduce operating profitability going forward.

Cybersecurity Threats Remain High Cybersecurity risks, including ransomware, pose threats to operations, data integrity, and could cause significant financial hardship.

Outlook

Expand Networks Via Acquisitions Plans focus on strengthening market presence through organic expansion and disciplined acquisition of new imaging centers.

Leverage AI Technology Investment Continue deploying DeepHealth OS and AI solutions to enhance operational efficiency and improve diagnostic quality across services.

Optimize Profitable Contracting Strategy includes regular evaluation and renegotiation of payor contracts to improve revenue terms and reduce overall expenses.

Scale Commercial Digital Health Intent to scale commercial Digital Health business, building on global customer base expansion to over 2,000 organizations.

Peer Comparison

Revenue (TTM)

OSCR

$11.70B

+27.5%

BLCO

$5.21B

+7.8%

BRKR

$3.44B

+2.1%

Gross Margin (Latest Quarter)

BLCO

99.9%

-1.0pp

KRYS

89.8%

+2.2pp

IRTC

70.9%

+2.3pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
PCVX	$8.19B	-10.1	-25.9%	7.5%
KRYS	$7.83B	37.6	18.7%	0.7%
BLCO	$5.82B	-26.5	-3.4%	0.3%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

5.1%

Steady Growth

4Q Net Income CAGR

N/M

Profitability Shift

Cash Flow Stability

100%

Strong Cash Flow

Deep Research

Next earnings:May 7, 2026

EPS:-

Revenue:-

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data